221 related articles for article (PubMed ID: 23043925)
1. Delay enhancement patterns in apical hypertrophic cardiomyopathy by phase-sensitive inversion recovery sequence.
Guo ZY; Chen J; Liang QZ; Liao HY; Fu SX; Tang QY; Chen CX; Han XJ; Gao F
Asian Pac J Trop Med; 2012 Oct; 5(10):828-30. PubMed ID: 23043925
[TBL] [Abstract][Full Text] [Related]
2. Myocardial scarring on cardiovascular magnetic resonance in asymptomatic or minimally symptomatic patients with "pure" apical hypertrophic cardiomyopathy.
Kim KH; Kim HK; Hwang IC; Lee SP; Park EA; Lee W; Kim YJ; Park JH; Sohn DW
J Cardiovasc Magn Reson; 2012 Jul; 14(1):52. PubMed ID: 22839526
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
Dumont CA; Monserrat L; Soler R; Rodríguez E; Fernández X; Peteiro J; Bouzas B; Piñón P; Castro-Beiras A
Rev Esp Cardiol; 2007 Jan; 60(1):15-23. PubMed ID: 17288951
[TBL] [Abstract][Full Text] [Related]
4. Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics.
Williams LK; Forero JF; Popovic ZB; Phelan D; Delgado D; Rakowski H; Wintersperger BJ; Thavendiranathan P
J Cardiovasc Magn Reson; 2017 Aug; 19(1):61. PubMed ID: 28784140
[TBL] [Abstract][Full Text] [Related]
5. Association of Late Gadolinium Enhancement and Degree of Left Ventricular Hypertrophy Assessed on Cardiac Magnetic Resonance Imaging With Ventricular Tachycardia in Children With Hypertrophic Cardiomyopathy.
Spinner JA; Noel CV; Denfield SW; Krishnamurthy R; Jeewa A; Dreyer WJ; Maskatia SA
Am J Cardiol; 2016 Apr; 117(8):1342-8. PubMed ID: 26892450
[TBL] [Abstract][Full Text] [Related]
6. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
[TBL] [Abstract][Full Text] [Related]
7. Frequency and distribution of late gadolinium enhancement in magnetic resonance imaging of patients with apical hypertrophic cardiomyopathy and patients with asymmetrical hypertrophic cardiomyopathy: a comparative study.
Yamada M; Teraoka K; Kawade M; Hirano M; Yamashina A
Int J Cardiovasc Imaging; 2009 Apr; 25 Suppl 1():131-8. PubMed ID: 19165622
[TBL] [Abstract][Full Text] [Related]
8. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.
Urbano-Moral JA; Rowin EJ; Maron MS; Crean A; Pandian NG
Circ Cardiovasc Imaging; 2014 Jan; 7(1):11-9. PubMed ID: 24275954
[TBL] [Abstract][Full Text] [Related]
9. Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.
Nucifora G; Muser D; Gianfagna P; Morocutti G; Proclemer A
Int J Cardiovasc Imaging; 2015 Dec; 31(8):1603-10. PubMed ID: 26210792
[TBL] [Abstract][Full Text] [Related]
10. Left atrial fibrosis correlates with extent of left ventricular myocardial delayed enhancement and left ventricular strain in hypertrophic cardiomyopathy.
Latif SR; Nguyen VQ; Peters DC; Soufer A; Henry ML; Grunseich K; Testani J; Hur DJ; Huber S; Mojibian H; Dicks D; Sinusas AJ; Meadows JL; Papoutsidakis N; Jacoby D; Baldassarre LA
Int J Cardiovasc Imaging; 2019 Jul; 35(7):1309-1318. PubMed ID: 30790116
[TBL] [Abstract][Full Text] [Related]
11. Left Atrial Performance in the Course of Hypertrophic Cardiomyopathy: Relation to Left Ventricular Hypertrophy and Fibrosis.
Kowallick JT; Silva Vieira M; Kutty S; Lotz J; Hasenfu G; Chiribiri A; Schuster A
Invest Radiol; 2017 Mar; 52(3):177-185. PubMed ID: 27741021
[TBL] [Abstract][Full Text] [Related]
12. Late gadolinium enhancement on cardiac magnetic resonance and phenotypic expression in hypertrophic cardiomyopathy.
Conte MR; Bongioanni S; Chiribiri A; Leuzzi S; Lardone E; Di Donna P; Pizzuti A; Luceri S; Cesarani F; Mabritto B; Zoccai GB; Bonamini R; Gaita F
Am Heart J; 2011 Jun; 161(6):1073-7. PubMed ID: 21641353
[TBL] [Abstract][Full Text] [Related]
13. Myocardial fibrosis progression on cardiac magnetic resonance in hypertrophic cardiomyopathy.
Choi HM; Kim KH; Lee JM; Yoon YE; Lee SP; Park EA; Lee W; Kim YJ; Cho GY; Sohn DW; Kim HK
Heart; 2015 Jun; 101(11):870-6. PubMed ID: 25897040
[TBL] [Abstract][Full Text] [Related]
14. Differences in apical and non-apical types of hypertrophic cardiomyopathy: a prospective analysis of clinical, echocardiographic, and cardiac magnetic resonance findings and outcome from 350 patients.
Kim EK; Lee SC; Hwang JW; Chang SA; Park SJ; On YK; Park KM; Choe YH; Kim SM; Park SW; Oh JK
Eur Heart J Cardiovasc Imaging; 2016 Jun; 17(6):678-86. PubMed ID: 26245912
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy: comparison of diagnostic performance in myocardial fibrosis between gadobutrol and gadopentetate dimeglumine.
Liu D; Ma X; Liu J; Zhao L; Chen H; Xu L; Sun Z; Fan Z
Int J Cardiovasc Imaging; 2017 Aug; 33(8):1191-1200. PubMed ID: 28289991
[TBL] [Abstract][Full Text] [Related]
16. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
[TBL] [Abstract][Full Text] [Related]
17. The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast-enhanced magnetic resonance study.
Weissler-Snir A; Hindieh W; Spears DA; Adler A; Rakowski H; Chan RH
J Cardiovasc Electrophysiol; 2019 May; 30(5):651-657. PubMed ID: 30680853
[TBL] [Abstract][Full Text] [Related]
18. The relationship between electrocardiographic changes and CMR features in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy.
Chen X; Zhao T; Lu M; Yin G; Xiangli W; Jiang S; Prasad S; Zhao S
Int J Cardiovasc Imaging; 2014 Jun; 30 Suppl 1():55-63. PubMed ID: 24723003
[TBL] [Abstract][Full Text] [Related]
19. Comparison of 3D phase-sensitive inversion-recovery and 2D inversion-recovery MRI at 3.0 T for the assessment of late gadolinium enhancement in patients with hypertrophic cardiomyopathy.
Morita K; Utsunomiya D; Oda S; Komi M; Namimoto T; Hirai T; Hashida M; Takashio S; Yamamuro M; Yamashita Y
Acad Radiol; 2013 Jun; 20(6):752-7. PubMed ID: 23473721
[TBL] [Abstract][Full Text] [Related]
20. Conductive channels identified with contrast-enhanced MR imaging predict ventricular tachycardia in systolic heart failure.
Lin LY; Su MY; Chen JJ; Lai LP; Hwang JJ; Tseng CD; Chen YS; Yu HY; Tseng WY; Lin JL
JACC Cardiovasc Imaging; 2013 Nov; 6(11):1152-9. PubMed ID: 24229767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
